What's new

Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 6, Status: Authorised

Jun 4, 2025 - 12:20
 0
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Ascletis scores phase 3 win for daily acne pill, prepares push to Chinese regula...

Next Article

Philippines signs deal for 12 fighter jets: S. Korea manufacturer

Related Posts

Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Summary of opinion: Rezolsta, 22/05/2025 Positive

Summary of opinion: Rezolsta, 22/05/2025 Positive

May 23, 2025  0